Protein compound, coding nucleotide sequences, producing cell line and uses thereof
CA 2130089 A1 · Owner: Mancini, Aldo · Inventors: Mancini, Aldo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a substantially proteinaceous composition which is capable of inhibiting selectively the division of estrogen-sensitive tumoral cells and/or of exerting a cytotoxic activity on such cells. This invention also relates to a cell line isolated from a human liposarcoma, capable of dividing in a culture, which produces said composition as well as to its culture, medium has been conditioned wherein said composition is present. This invention also relates to the various uses of said products in diagnostic and clinical applications.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 8, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.